GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3776 - 3800 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 4 12 mild
G10133VD
2453
IgG Patient 3 4 mild
G68461PT
2454
IgM Patient 3 4 mild
G80587NA
2467
IgA Patient 3 -180 mild
G36374CE
2500
IgA Patient 3 -180 mild
G12200GB
2501
IgA Patient 2 24 mild
G21675ZL
2502
IgA Patient 3 4 mild
G82204SH
2515
IgA Patient 3 -180 mild
G26125KY
2520
IgA Patient 3 11 mild
G26125KY
2531
IgG Patient 3 -180 mild
G64669AQ
2537
IgG Patient 2 15 mild
G47362BJ
2542
IgG Patient 1 10 moderate
G90562PB
2569
IgM Patient 4 12 mild
G82096UQ
2572
IgG Patient 3 4 mild
G08340FW
2573
IgG Patient 2 3 mild
G26295XE
2574
IgM Patient 2 24 mild
G00066MO
2600
IgA Patient 3 4 mild
G26125KY
2601
IgA Patient 3 11 mild
G17689EW
2625
IgA Patient 3 11 mild
G14569AR
2641
IgA Patient 2 15 mild
G15407YE
2656
IgA Patient 3 -180 mild
G68703KI
2658
IgA Patient 3 11 mild
G36374CE
2659
IgA Patient 3 4 mild
G11460AB
2698
IgA Patient 3 -180 mild
G17689EW
2705
IgM Patient 3 11 mild
G80587NA
2717

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024